These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features. Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence? Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486 [TBL] [Abstract][Full Text] [Related]
8. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma. Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555 [TBL] [Abstract][Full Text] [Related]
9. Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis. Catasus L; Gallardo A; Cuatrecasas M; Prat J Mod Pathol; 2009 Apr; 22(4):522-9. PubMed ID: 19234438 [TBL] [Abstract][Full Text] [Related]
10. KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer. Mao C; Zhou J; Yang Z; Huang Y; Wu X; Shen H; Tang J; Chen Q PLoS One; 2012; 7(5):e36653. PubMed ID: 22586484 [TBL] [Abstract][Full Text] [Related]
11. EGFR, PIK3CA and PTEN gene status and their protein product expression in neuroblastic tumours. Izycka-Swieszewska E; Brzeskwiniewicz M; Wozniak A; Drozynska E; Grajkowska W; Perek D; Balcerska A; Klepacka T; Limon J Folia Neuropathol; 2010; 48(4):238-45. PubMed ID: 21225506 [TBL] [Abstract][Full Text] [Related]
12. PTEN-deficient cancers depend on PIK3CB. Wee S; Wiederschain D; Maira SM; Loo A; Miller C; deBeaumont R; Stegmeier F; Yao YM; Lengauer C Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13057-62. PubMed ID: 18755892 [TBL] [Abstract][Full Text] [Related]
13. PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer. Sood A; McClain D; Maitra R; Basu-Mallick A; Seetharam R; Kaubisch A; Rajdev L; Mariadason JM; Tanaka K; Goel S Clin Colorectal Cancer; 2012 Jun; 11(2):143-50. PubMed ID: 22285706 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/PTEN, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of PTEN is associated with worse clinical outcome. Bettstetter M; Berezowska S; Keller G; Walch A; Feuchtinger A; Slotta-Huspenina J; Feith M; Drecoll E; Höfler H; Langer R Hum Pathol; 2013 May; 44(5):829-36. PubMed ID: 23158210 [TBL] [Abstract][Full Text] [Related]
15. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN. Chong X; Chen J; Zheng N; Zhou Z; Hai Y; Chen S; Zhang Y; Yu Q; Yu S; Chen Z; Bao W; Quan M; Chen ZS; Zhan Y; Gao Y Mol Cancer; 2022 May; 21(1):118. PubMed ID: 35619132 [TBL] [Abstract][Full Text] [Related]
16. PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3'-kinase pathway alterations might be associated with favorable prognosis. Dong Y; Yang X; Wong O; Zhang X; Liang Y; Zhang Y; Wong W; Nong L; Liao Q; Li T Hum Pathol; 2012 Aug; 43(8):1197-205. PubMed ID: 22209294 [TBL] [Abstract][Full Text] [Related]
17. Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women. Deng L; Chen J; Zhong XR; Luo T; Wang YP; Huang HF; Yin LJ; Qiu Y; Bu H; Lv Q; Zheng H PLoS One; 2015; 10(3):e0120511. PubMed ID: 25816324 [TBL] [Abstract][Full Text] [Related]
18. Roles of genetic variants in the PI3K/PTEN pathways in susceptibility to colorectal carcinoma and clinical outcomes treated with FOLFOX regimen. Lin L; Zhang Z; Zhang W; Wang L; Wang J Int J Clin Exp Pathol; 2015; 8(10):13314-22. PubMed ID: 26722535 [TBL] [Abstract][Full Text] [Related]
19. Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer. Ekstrand AI; Jönsson M; Lindblom A; Borg A; Nilbert M Fam Cancer; 2010 Jun; 9(2):125-9. PubMed ID: 19731079 [TBL] [Abstract][Full Text] [Related]
20. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma]. Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]